Recently, biology professor Anding Shen landed a $300, 000 grant from the National Institutes of Health (NIH) to study the role of endothelial cells in HIV infection—a project that will occupy her for ...
A study published on Sept. 17 in PLOS Pathogens reports results from a clinical trial of an histone deacetylases (HDAC) inhibitor that had shown potential in preclinical studies and answers open ...
However, activating NF-kB also has the affect of loosening chromatin, which HIV recruits in another mechanism of latency. Therefore, upregulating the viral activator would be "good for both of these ...
More than 20 years after the discovery of combination antiretroviral therapy (ART), complete eradication of HIV infection has not yet been achieved. While ART controls viral replication, it is not a ...
Researchers from the University of Illinois have demonstrated the importance of cell-type-specific targeting in the treatment of HIV. Their study, published in the Proceedings of the National Academy ...
An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, ...
A major bottleneck in curing HIV (human immunodeficiency virus) is that the virus can hide in an inactive form within resting white blood cells, which play a crucial role in coordinating the immune ...
An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results